OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Intranasal vaccines are showing promise, but there are multiple formulation hurdles to overcome.
The delivery platform depends on API-related factors, and the development stage of the product.
January 18, 2022
In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.
January 17, 2022
Protective external packaging ensures COVID-19 vaccines arrive safely.
January 11, 2022
The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.
January 07, 2022
Intravacc is partnering with Leiden University Medical Center for the development and evaluation of a new intranasal coronavirus vaccine candidate in a clinical Phase I/II study.
January 06, 2022
Smart manufacturing transforms management of tablet and capsule equipment and processes.
January 03, 2022
Workforce training is crucial for biopharmaceutical manufacturing.
December 10, 2021
Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.
December 03, 2021
Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.
Increased patient-centricity and alternative dosage forms require careful consideration when selecting the best taste-masking approach.
December 01, 2021
CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.